擅长血脂异常与动脉粥样硬化，高血压的治疗。Management of dyslipidemia, atherosclerosis and hypertension.

常炳习北京协和医院心内科 副主任医师，副教授。1987年毕业于山东医科大学医学系，工作至今一直从事心血管内科临床、教学和科研工作。参与过多部国内心血管专著的编写，2000年4月至2002年8月在美国华盛顿大学动脉粥样硬化研究中心做访问学者，并发表了多篇有关血脂研究的学术论文。多年来，在血脂异常与动脉粥样硬化、高血压及心力衰竭等疾病的诊断、治疗中积累了丰富的临床经验。论文与论著：1、DDD Pacemaker for Treatment Hypertrophic Cardiomyopathy. U.S. Chinese Health and Hygiene Journal 1998;（Chang Bing-Xi, Tang Bang-Xi, Xu Nan-Tu.）2、Intravenous thromblic therapy for acute myocardial infarction using recombinant tissue profibrinolysin activator. Chinese Medical Journal of English 1998:111(9)（ Chang Bing-Xi, Tang Bang-Xi, Xu Nan-Tu et al）3、Protective effect of intensive ant hypertension therapy on target organ damage: Result from prevention of Adverse outcome with treatment of hypertension (PATH) study. Oral presentation at AHA Congress in Chicago, 2002。（Chang Bing-xi, Xu Nan-tu, Zhao Xue-qiao.）4、Single nucleotide polymorphisms and haplotype of four genes encoding cardiac ion channels in Chinese and their association with arrhythmia Journal: Annals of Noninvasive Electrocardiology.2008; (Yu Zhang, Bingxi Chang, et al.)

1、DDD Pacemaker for Treatment Hypertrophic Cardiomyopathy. U.S. Chinese Health and Hygiene Journal 1998;(Chang Bing-Xi, Tang Bang-Xi, Xu Nan-Tu.)

2、Intravenous thromblic therapy for acute myocardial infarction using recombinant tissue profibrinolysin activator. Chinese Medical Journal of English 1998:111(9)( Chang Bing-Xi, Tang Bang-Xi, Xu Nan-Tu et al)

3、Protective effect of intensive ant hypertension therapy on target organ damage: Result from prevention of Adverse outcome with treatment of hypertension (PATH) study. Oral presentation at AHA Congress in Chicago, 2002。(Chang Bing-xi, Xu Nan-tu, Zhao Xue-qiao.)

4、Single nucleotide polymorphisms and haplotype of four genes encoding cardiac ion channels in Chinese and their association with arrhythmia Journal: Annals of Noninvasive Electrocardiology.2008; (Yu Zhang, Bingxi Chang, et al.)